Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical OfficerGlobeNewsWire • 02/25/21
Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe DiseaseGlobeNewsWire • 02/01/21
Will Spark Therapeutics (ONCE) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/29/19
Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology ProductGlobeNewsWire • 10/25/19
Gene Therapy Stocks Rocket On Rumor Roche Clinched Its Spark BuyoutInvestors Business Daily • 10/24/19
Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs) Access Genetic TestingGlobeNewsWire • 09/18/19
Spark Therapeutics Announces Change of Location for Annual Meeting of StockholdersGlobeNewsWire • 08/27/19
Analysts Estimate Spark Therapeutics (ONCE) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/30/19
Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019Investors Business Daily • 07/10/19
Why This Gene Therapy Stock Looks Like A Sure Takeover Bet: AnalystInvestors Business Daily • 06/17/19
Why Coeur Mining, Spark Therapeutics, and Tandem Diabetes Care Slumped TodayThe Motley Fool • 06/10/19